Clinical Trial 56728

Orange, CA 92868


Summary:

Cirrhosis is severe scarring of the liver. The liver damage caused by cirrhosis generally can't be undone. But if liver cirrhosis is diagnosed early and the underlying cause is treated, further damage can be limited.

A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)



Criteria:
  • Male and female adults ≥18 years of age
  • Diagnosed with cirrhosis
  • Fibrosis Stage 4


Qualified Participants May Receive:

Up to $2000


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.